Xiaohui Zhang

Research interests

Publications

• The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update

  Journal of Hematology & Oncology · 2021 · https://doi.org/10.1186/s13045-021-01159-2

• Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients

  Journal of Hematology & Oncology · 2019 · https://doi.org/10.1186/s13045-019-0781-y

• Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

  Blood · 2015 · https://doi.org/10.1182/blood-2015-02-627786

• Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets

  Journal of Hematology & Oncology · 2015 · https://doi.org/10.1186/s13045-015-0182-9

• Who is the best donor for a related HLA haplotype-mismatched transplant?

  Blood · 2014 · https://doi.org/10.1182/blood-2014-03-563130

• MRD-directed risk stratification treatment may improve outcomes of t(8;21) AML in the first complete remission: results from the AML05 multicenter trial

  Blood · 2013 · https://doi.org/10.1182/blood-2012-11-468348

• Long‐term follow‐up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia

  Cancer · 2012 · https://doi.org/10.1002/cncr.27761

• Treatment of Acute Leukemia with Unmanipulated HLA-Mismatched/Haploidentical Blood and Bone Marrow Transplantation

  Transplantation and Cellular Therapy · 2009 · https://doi.org/10.1016/j.bbmt.2008.11.025

Current projects

No projects listed.